These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2741971)

  • 1. Methotrexate treatment in scleroderma.
    van den Hoogen FH; Boerbooms AM; van de Putte LB
    Am J Med; 1989 Jul; 87(1):116-7. PubMed ID: 2741971
    [No Abstract]   [Full Text] [Related]  

  • 2. Indirect evidence for the efficacy of methotrexate in diffuse systemic sclerosis.
    Low AH; Lee P
    J Rheumatol; 2008 Nov; 35(11):2286. PubMed ID: 19004063
    [No Abstract]   [Full Text] [Related]  

  • 3. [Scleroderma and Gougerot-Sjögren syndrome. Effect of methotrexate therapy].
    Welin J; Grolleau JY; Barrière H
    Sem Hop Ther; 1973 Jan; 49(1):37-41. PubMed ID: 4712023
    [No Abstract]   [Full Text] [Related]  

  • 4. Methotrexate shows marginal clinical efficiency in early scleroderma.
    Varga J
    Curr Rheumatol Rep; 2002 Apr; 4(2):97-8. PubMed ID: 11890873
    [No Abstract]   [Full Text] [Related]  

  • 5. Photochemotherapy and methotrexate used to treat generalized cutaneous scleroderma.
    Ridge CA; Moktar A; Barry J; Murphy GM
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):692-3. PubMed ID: 17447992
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate for the treatment of early diffuse scleroderma: comment on the article by Pope et al.
    Lehman TJ
    Arthritis Rheum; 2002 Mar; 46(3):845. PubMed ID: 11920427
    [No Abstract]   [Full Text] [Related]  

  • 7. Low dose methotrexate treatment in systemic sclerosis.
    van den Hoogen FH; Boerbooms AM; van de Putte LB; Rasker JJ; van Venrooij WJ
    J Rheumatol; 1991 Nov; 18(11):1763-4. PubMed ID: 1787505
    [No Abstract]   [Full Text] [Related]  

  • 8. Methotrexate has no antifibrotic effect in bleomycin-induced experimental scleroderma.
    Ozgen M; Koca SS; Isik A; Ozercan IH
    J Rheumatol; 2010 Mar; 37(3):678-9. PubMed ID: 20197571
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of antimetabolites in diseases of auto-aggression].
    Romiti N
    Hospital (Rio J); 1968 Jan; 73(1):71-8. PubMed ID: 5308511
    [No Abstract]   [Full Text] [Related]  

  • 10. Disappearance of circulating autoantibodies to RNA polymerase III in a patient with systemic sclerosis successfully treated with corticosteroid and methotrexate.
    Tanahashi K; Sugiura K; Muro Y; Akiyama M
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1453-4. PubMed ID: 24916000
    [No Abstract]   [Full Text] [Related]  

  • 11. Localized and systemic scleroderma show different histological responses to methotrexate therapy.
    Seyger MM; van den Hoogen FH; van Vlijmen-Willems IM; van de Kerkhof PC; de Jong EM
    J Pathol; 2001 Apr; 193(4):511-6. PubMed ID: 11276011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of systemic sclerosis.
    Medsger TA
    Curr Opin Rheumatol; 1990 Dec; 2(6):956-9. PubMed ID: 2128028
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of methotrexate in patients with scleroderma and mixed connective tissue disease.
    Kowal-Bielecka O; Distler O
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S160-3. PubMed ID: 21044452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo controlled trial of methotrexate in systemic sclerosis.
    Das SN; Alam MR; Islam N; Rahman MH; Sutradhar SR; Rahman S; Khan GK; Rahim A; Haq SA
    Mymensingh Med J; 2005 Jan; 14(1):71-4. PubMed ID: 15695960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic interventions in systemic sclerosis.
    van den Hoogen FH
    Neth J Med; 1998 Sep; 53(3):137-8. PubMed ID: 9803147
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of "collagen and autoimmune" diseases (author's transl)].
    Kerl H; Klein G; Sandhofer M
    Wien Klin Wochenschr; 1973 Nov; 85(47):769-74. PubMed ID: 4757177
    [No Abstract]   [Full Text] [Related]  

  • 17. Variability of skin scores and clinical measurements in scleroderma.
    Pope JE; Baron M; Bellamy N; Campbell J; Carette S; Chalmers I; Dales P; Hanly J; Kaminska EA; Lee P
    J Rheumatol; 1995 Jul; 22(7):1271-6. PubMed ID: 7562757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of oral methotrexate in the treatment of systemic sclerosis.
    Krishna Sumanth M; Sharma VK; Khaitan BK; Kapoor A; Tejasvi T
    Int J Dermatol; 2007 Feb; 46(2):218-23. PubMed ID: 17269983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple stress fractures in a scleroderma patient on methotrexate therapy.
    Singwe M; Le Gars L; Karneff A; Prier A; Kaplan G
    Rev Rhum Engl Ed; 1998; 65(7-9):508-10. PubMed ID: 9785399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate therapy in polymyositis.
    Arnett FC; Whelton JC; Zizic TM; Stevens MB
    Ann Rheum Dis; 1973 Nov; 32(6):536-46. PubMed ID: 4760477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.